Skip to main content
SpringerLink
Log in

Chemokines and Chemokine Receptors in Cancer Progression

  • Chapter
  • First Online:
Book cover Chemokine Receptors in Cancer

Part of the book series: Cancer Drug Discovery and Development ((CDD&D))

  • 845 Accesses

Abstract

Directed cell migration is a fundamental component of numerous biological systems and is critical to the pathology of many diseases. Although the importance of chemokines in providing navigational cues to migrating cells bearing specific receptors is well-established, how chemokine function is regulated is not so well understood and may be of key importance to the design of new therapeutics for numerous human diseases, particularly for the control of cancer growth and metastasis, diseases in which chemokines have recently been implicated. In this review, we discuss the general views on the role of specific chemokines in these pathological processes. In addition, we discuss two novel aspects of chemokine cancer biology; cross-talk between chemokine and growth factor receptors, and refractory chemokine receptors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Adams, T. E., Epa, V. C., et al. (2000). Structure and function of the type 1 insulin-like growth factor receptor. Cell Mol Life Sci 57(7): 1050–93.

    Article  PubMed  CAS  Google Scholar 

  2. Akekawatchai, C., Holland, J. D., et al. (2005). Transactivation of CXCR4 by the insulin-like growth factor-1 receptor (IGF-1R) in human MDA-MB-231 breast cancer epithelial cells. J Biol Chem 280(48): 39701–8. Epub 2005 Sep 19.

    Article  PubMed  CAS  Google Scholar 

  3. Andrechek, E. R. and Muller, W. J. (2000). Tyrosine kinase signalling in breast cancer: tyrosine kinase-mediated signal transduction in transgenic mouse models of human breast cancer. Breast Cancer Res 2(3): 211–6.

    Article  PubMed  CAS  Google Scholar 

  4. Angiolillo, A. L., Sgadari, C., et al. (1995). Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J Exp Med 182(1): 155–62.

    Article  PubMed  CAS  Google Scholar 

  5. Arenberg, D. A., Kunkel, S. L., et al. (1996). Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. J Exp Med 184(3): 981–92.

    Article  PubMed  CAS  Google Scholar 

  6. Arenberg, D. A., Polverini, P. J., et al. (1997). The role of CXC chemokines in the regulation of angiogenesis in non-small cell lung cancer. J Leukoc Biol 62(5): 554–62.

    PubMed  CAS  Google Scholar 

  7. Arya, M., Patel, H. R., et al. (2003). Chemokines: Key players in cancer. Curr Med Res Opin 19(6): 557–64.

    Article  PubMed  CAS  Google Scholar 

  8. Bae, M. H., Lee, M. J., et al. (1998). Insulin-like growth factor II (IGF-II) secreted from HepG2 human hepatocellular carcinoma cells shows angiogenic activity. Cancer Lett 128(1): 41–6.

    Article  PubMed  CAS  Google Scholar 

  9. Bais, Santomasso, C., B., et al. (1998). G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 391(6662): 86–9.

    Google Scholar 

  10. Bajetto, A., Bonavia, R., et al. (1999). Glial and neuronal cells express functional chemokine receptor CXCR4 and its natural ligand stromal cell-derived factor 1. J Neurochem 73(6): 2348–57.

    Article  PubMed  CAS  Google Scholar 

  11. Balkwill, F. (1998). The molecular and cellular biology of the chemokines. J Viral Hepat 5(1): 1–14.

    Article  PubMed  CAS  Google Scholar 

  12. Balkwill, F. (2002). Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev 13(2): 135–41.

    Article  PubMed  CAS  Google Scholar 

  13. Balkwill, F. (2004). Cancer and the chemokine network. Nat Rev Cancer 4(7): 540–50.

    Article  PubMed  CAS  Google Scholar 

  14. Balkwill, F. (2004). The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol 14(3): 171–9.

    Article  PubMed  CAS  Google Scholar 

  15. Baserga (1995)

    Google Scholar 

  16. Baserga, R., Peruzzi, F. et al. (2003). The IGF-1 receptor in cancer biology. Int J Cancer 107(6): 873–7.

    Article  PubMed  CAS  Google Scholar 

  17. Becker, C., Fantini, M. C., et al. (2004). TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. Immunity 21(4): 491–501.

    Article  PubMed  CAS  Google Scholar 

  18. Brigati, C.,. Noonan, D. M., et al. (2002). Tumors and inflammatory infiltrates: friends or foes? Clin Exp Metastasis 19(3): 247–58.

    Article  PubMed  CAS  Google Scholar 

  19. Burger, M., Burger, J. A., et al. (1999). Point mutation causing constitutive signaling of CXCR2 leads to transforming activity similar to Kaposi's sarcoma herpesvirus-G protein-coupled receptor. J Immunol 163(4): 2017–22.

    PubMed  CAS  Google Scholar 

  20. Cameron, M. D., Schmidt, E. E., et al. (2000). Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency. Cancer Res 60(9): 2541–6.

    PubMed  CAS  Google Scholar 

  21. Cardones, A. R., Murakami, T., et al. (2003). CXCR4 enhances adhesion of B16 tumor cells to endothelial cells in vitro and in vivo via beta(1) integrin. Cancer Res 63(20): 6751–7.

    PubMed  CAS  Google Scholar 

  22. Chambers, A. F., Groom, A. C., et al. (2002). Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2(8): 563–72.

    Article  PubMed  CAS  Google Scholar 

  23. Chen, G. S., Yu, H. S., et al. (2006). CXC chemokine receptor CXCR4 expression enhances tumorigenesis and angiogenesis of basal cell carcinoma. Br J Dermatol 154(5): 910–8.

    Article  PubMed  CAS  Google Scholar 

  24. Chen, Y., Stamatoyannopoulos, G., et al. (2003). Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro. Cancer Res 63(16): 4801–4.

    PubMed  CAS  Google Scholar 

  25. Cobleigh, M. A., Vogel, C. L., et al. (1999). Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J Clin Oncol 17(9): 2639–48.

    PubMed  CAS  Google Scholar 

  26. Coussens, L. M. and Werb Z. (2002). Inflammation and cancer. Nature 420(6917): 860–7.

    Article  PubMed  CAS  Google Scholar 

  27. Cullen, K. J., Yee, D., et al. (1990). Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res 50(1): 48–53.

    PubMed  CAS  Google Scholar 

  28. Curnock, A. P., Logan, M. K., et al. (2002). Chemokine signalling: pivoting around multiple phosphoinositide 3-kinases. Immunology 105(2): 125–36.

    Article  PubMed  CAS  Google Scholar 

  29. De Larco, J. E., Wuertz, B. R., et al. (2001). A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells. Am J Pathol 158(2): 639–46.

    Article  PubMed  Google Scholar 

  30. Denley, A., Cosgrove, L. J., et al. (2005). Molecular interactions of the IGF system. Cytokine Growth Factor Rev 16(4–5): 421–39.

    Article  PubMed  CAS  Google Scholar 

  31. Doerr (1996)

    Google Scholar 

  32. Dunn, S. E., Ehrlich, M., et al. (1998). A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer. Cancer Res 58(15): 3353–61.

    PubMed  CAS  Google Scholar 

  33. Ferrer, F. A., Miller, L. J., et al. (1998). Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells. Urology 51(1): 161–7.

    Article  PubMed  CAS  Google Scholar 

  34. Fidler, I. J. (1970). Metastasis: guantitative analysis of distribution and fate of tumor embolilabeled with 125 I-5-iodo-2'-deoxyuridine. J Natl Cancer Inst 45(4): 773–82.

    PubMed  CAS  Google Scholar 

  35. Fidler, I. J. (2002). The organ microenvironment and cancer metastasis. Differentiation 70 (9–10): 498–505.

    Article  PubMed  Google Scholar 

  36. Fidler, I. J. (2003). Timeline: The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3(6): 453–8.

    Article  PubMed  CAS  Google Scholar 

  37. Foulstone, E., Prince, S., et al. (2005). Insulin-like growth factor ligands, receptors, and binding proteins in cancer. J Pathol 205(2): 145–53.

    Article  PubMed  CAS  Google Scholar 

  38. Furukawa, M., Raffeld, M., et al. (2005). Increased expression of insulin-like growth factor I and/or its receptor in gastrinomas is associated with low curability, increased growth, and development of metastases. Clin Cancer Res 11(9): 3233–42.

    Article  PubMed  CAS  Google Scholar 

  39. Gale, L. M. and McColl, S. R. (1999). Chemokines: extracellular messengers for all occasions? Bioessays 21(1): 17–28.

    Article  PubMed  CAS  Google Scholar 

  40. Ganju, R. K., Brubaker, S. A., et al. (1998). The alpha-chemokine, stromal cell-derived factor-1alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. J Biol Chem 273(36): 23169–75.

    Article  PubMed  CAS  Google Scholar 

  41. Gross, J. M. and Yee, D. (2003). The type-1 insulin-like growth factor receptor tyrosine kinase and breast cancer: biology and therapeutic relevance. Cancer Metastasis Rev 22(4): 327–36.

    Article  PubMed  CAS  Google Scholar 

  42. Gupta, S. K., Lysko, P. G., et al. (1998). Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines. J Biol Chem 273(7): 4282–7.

    Article  PubMed  CAS  Google Scholar 

  43. Holland, J. D., Kochetkova, M., et al. (2006). Differential functional activation of chemokine receptor CXCR4 is mediated by G proteins in breast cancer cells. Cancer Res 66(8): 4117–24.

    Article  PubMed  CAS  Google Scholar 

  44. Hopfner, M., Schuppan, D. et al. (2008). Growth factor receptors and related signalling pathways as targets for novel treatment strategies of hepatocellular cancer. World J Gastroenterol 14(1): 1–14.

    Article  PubMed  CAS  Google Scholar 

  45. Hu, Y. F., Lau, K. M., et al. (1998). Increased expression of estrogen receptor beta in chemically transformed human breast epithelial cells. Int J Oncol 12(6): 1225–8.

    PubMed  CAS  Google Scholar 

  46. Hynes, N. E. (2000). Tyrosine kinase signalling in breast cancer. Breast Cancer Res 2(3): 154–7. Epub 2000 Apr 17.

    Article  PubMed  CAS  Google Scholar 

  47. Inoue, K., Slaton, J. W., et al. (2000). Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. Clin Cancer Res 6(5): 2104–19.

    PubMed  CAS  Google Scholar 

  48. Jaiswal, M., LaRusso, N. F., et al. (2000). Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res 60(1): 184–90.

    PubMed  CAS  Google Scholar 

  49. Kakinuma, T. and Hwang S. T. (2006). Chemokines, chemokine receptors, and cancer metastasis. J Leukoc Biol 79(4): 639–51.

    Article  PubMed  CAS  Google Scholar 

  50. Kawada, K., Sonoshita, M., et al. (2004). Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes. Cancer Res 64(11): 4010–7.

    Article  PubMed  CAS  Google Scholar 

  51. Klijn, J. G., Berns, P. M., et al. (1992). The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. Endocr Rev 13(1): 3–17.

    PubMed  CAS  Google Scholar 

  52. Kornprat, P., Rehak, P., et al. (2006). Expression of IGF-I, IGF-II, and IGF-IR in gallbladder carcinoma. A systematic analysis including primary and corresponding metastatic tumours. J Clin Pathol 59(2): 202–6.

    Article  PubMed  CAS  Google Scholar 

  53. Krause, D. S. and Van Etten R. A. (2005). Tyrosine kinases as targets for cancer therapy. N Engl J Med 353(2): 172–87.

    Article  PubMed  CAS  Google Scholar 

  54. Lee, O. H., Bae, S. K., et al. (2000). Identification of angiogenic properties of insulin-like growth factor II in in vitro angiogenesis models. Br J Cancer 82(2): 385–91.

    Article  PubMed  CAS  Google Scholar 

  55. Liang, Z., Yoon, Y.,et al. (2005). Silencing of CXCR4 blocks breast cancer metastasis. Cancer Res 65(3): 967–71.

    PubMed  CAS  Google Scholar 

  56. Lin, E. Y. and Pollard J. W. (2004). Role of infiltrated leucocytes in tumour growth and spread. Br J Cancer 90(11): 2053–8.

    Article  PubMed  CAS  Google Scholar 

  57. Liotta, L. A. (2001). An attractive force in metastasis. Nature 410(6824): 24–5.

    Article  PubMed  CAS  Google Scholar 

  58. Liotta, L. A. and. Kohn E. C (2001). The microenvironment of the tumour-host interface. Nature 411(6835): 375–9.

    Google Scholar 

  59. Liu, J. P., Baker, J., et al. (1993). Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75(1): 59–72.

    PubMed  CAS  Google Scholar 

  60. Long, L., Rubin, R., et al. (1995). Loss of the metastatic phenotype in murine carcinoma cells expressing an antisense RNA to the insulin-like growth factor receptor. Cancer Res 55(5): 1006–9.

    PubMed  CAS  Google Scholar 

  61. Lopez-Ilasaca, M. (1998). Signaling from G-protein-coupled receptors to mitogen-activated protein (MAP)-kinase cascades. Biochem Pharmacol 56(3): 269–77.

    Article  PubMed  CAS  Google Scholar 

  62. Lu, H., Ouyang, W., et al. (2006). Inflammation, a key event in cancer development. Mol Cancer Res 4(4): 221–33.

    Article  PubMed  CAS  Google Scholar 

  63. Luan, J., Shattuck-Brandt, R., et al. (1997). Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression. J Leukoc Biol 62(5): 588–97.

    PubMed  CAS  Google Scholar 

  64. Luttrell, L. M., Daaka, Y., et al. (1999). Regulation of tyrosine kinase cascades by G-protein-coupled receptors. Curr Opin Cell Biol 11(2): 177–83.

    Article  PubMed  CAS  Google Scholar 

  65. Luzzi, K. J., MacDonald, I. C., et al. (1998). Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 153(3): 865–73.

    Article  PubMed  CAS  Google Scholar 

  66. Majka, M., Ratajczak, J., et al. (2000). Binding of stromal derived factor-1alpha (SDF-1alpha) to CXCR4 chemokine receptor in normal human megakaryoblasts but not in platelets induces phosphorylation of mitogen-activated protein kinase p42/44 (MAPK), ELK-1 transcription factor and serine/threonine kinase AKT. Eur J Haematol 64(3): 164–72.

    Article  PubMed  CAS  Google Scholar 

  67. Mauro, L. and Surmacz E. (2004). IGF-I receptor, cell–cell adhesion, tumour development and progression. J Mol Histol 35(3): 247–53.

    Article  PubMed  CAS  Google Scholar 

  68. Mellado, M., Rodriguez-Frade, J. M., et al. (2001). Chemokine signaling and functional responses: the role of receptor dimerization and TK pathway activation. Annu Rev Immunol 19: 397–421.

    Article  PubMed  CAS  Google Scholar 

  69. Mitra, P., De, A., et al. (2001). Loss of chemokine SDF-1alpha-mediated CXCR4 signalling and receptor internalization in human hepatoma cell line HepG2. Cell Signal 13(5): 311–9.

    Article  PubMed  CAS  Google Scholar 

  70. Moore, B. B., Arenberg, D. A., et al. (1999). Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells. Am J Pathol 154(15): 1503–12.

    Google Scholar 

  71. Moore, M. A. (2001). The role of chemoattraction in cancer metastases. Bioessays 23(8): 674–6.

    Article  PubMed  CAS  Google Scholar 

  72. Moser, B., L. Barella, et al. (1993). Expression of transcripts for two interleukin 8 receptors in human phagocytes, lymphocytes and melanoma cells. Biochem J 294(Pt 1): 285–92.

    PubMed  CAS  Google Scholar 

  73. Muller, A., Homey, B., et al. (2001). Involvement of chemokine receptors in breast cancer metastasis. Nature 410(6824): 50–6.

    Article  PubMed  CAS  Google Scholar 

  74. Murakami, T., Maki, W., et al. (2002). Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Res 62(24): 7328–34.

    PubMed  CAS  Google Scholar 

  75. Murphy, P. M. (2001). Chemokines and the molecular basis of cancer metastasis. N Engl J Med 345(11): 833–5.

    Article  PubMed  CAS  Google Scholar 

  76. Musha, H., Ohtani, H., et al. (2005). Selective infiltration of CCR5(+)CXCR3(+) T lymphocytes in human colorectal carcinoma. Int J Cancer 116(6): 949–56.

    Article  PubMed  CAS  Google Scholar 

  77. Nagasawa, T., Hirota, S., et al. (1996). Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382(6592): 635–8.

    Article  PubMed  CAS  Google Scholar 

  78. Nahta, R., Hortobagyi, G. N., et al. (2003). Growth factor receptors in breast cancer: potential for therapeutic intervention. Oncologist 8(1): 5–17.

    Article  PubMed  CAS  Google Scholar 

  79. Negus, R. P., Stamp, G. W., et al. (1997). Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. Am J Pathol 150(5): 1723–34.

    PubMed  CAS  Google Scholar 

  80. Neves, S. R., Ram, P. T., et al. (2002). G protein pathways. Science 296(5573): 1636–9.

    Article  PubMed  CAS  Google Scholar 

  81. Nguyen, D. H. and Taub, D. (2002). CXCR4 function requires membrane cholesterol: implications for HIV infection. J Immunol 168(8): 4121–6.

    PubMed  CAS  Google Scholar 

  82. Nicolson, G. L. (1993). Cancer progression and growth: relationship of paracrine and autocrine growth mechanisms to organ preference of metastasis. Exp Cell Res 204(2): 171–80.

    Article  PubMed  CAS  Google Scholar 

  83. Norgauer, J., Metzner, B., et al. (1996). Expression and growth-promoting function of the IL-8 receptor beta in human melanoma cells. J Immunol 156(3): 1132–37.

    PubMed  CAS  Google Scholar 

  84. Ohta, M., Kitadai, Y.,et al. (2002). Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas. Int J Cancer 102(3): 220–4.

    Article  PubMed  CAS  Google Scholar 

  85. Owen, J. D., Strieter, R., et al. (1997). Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine beta and gamma proteins. Int J Cancer 73(1): 94–103.

    Article  PubMed  CAS  Google Scholar 

  86. Papa, V., Gliozzo, B., et al. (1993). Insulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer. Cancer Res 53(16): 3736–40.

    PubMed  CAS  Google Scholar 

  87. Peyrat, J. P. and Bonneterre, J (1992). Type 1 IGF receptor in human breast diseases. Breast Cancer Res Treat 22(1): 59–67.

    Article  PubMed  CAS  Google Scholar 

  88. Pike, L. J. (2003). Lipid rafts: bringing order to chaos. J Lipid Res 44(4): 655–67. Epub 2003 Feb 1.

    Article  PubMed  CAS  Google Scholar 

  89. Pike, L. J. (2004). Lipid rafts: heterogeneity on the high seas. Biochem J 378(Pt 2): 281–92.

    Article  PubMed  CAS  Google Scholar 

  90. Polyak, K. (2001). On the birth of breast cancer. Biochim Biophys Acta 1552(1): 1–13.

    PubMed  CAS  Google Scholar 

  91. Pyne, N. J., Waters, C., et al. (2003). Receptor tyrosine kinase-GPCR signal complexes. Biochem Soc Trans 31(Pt 6): 1220–5.

    Article  PubMed  CAS  Google Scholar 

  92. Rahmatullah, M. and Robishaw, J. D. (1994). Direct interaction of the alpha and gamma subunits of the G proteins. Purification and analysis by limited proteolysis. J Biol Chem 269(5): 3574–80.

    PubMed  CAS  Google Scholar 

  93. Remacle-Bonnet, M., Garrouste, F., et al. (2005). Membrane rafts segregate pro- from anti-apoptotic insulin-like growth factor-I receptor signaling in colon carcinoma cells stimulated by members of the tumor necrosis factor superfamily. Am J Pathol 167(3): 761–73.

    Article  PubMed  CAS  Google Scholar 

  94. Robinson, S. C., Scott, K. A., et al. (2002). Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF-alpha. Eur J Immunol 32(2): 404–12.

    Article  PubMed  CAS  Google Scholar 

  95. Robledo, M. M., Bartolome, R. A.,et al. (2001). Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells. J Biol Chem 276(48): 45098–105.

    Article  PubMed  CAS  Google Scholar 

  96. Rogers, C. E., Loveday, R. L., et al. (2002). Molecular prognostic indicators in breast cancer. Eur J Surg Oncol 28(5): 467–78.

    PubMed  CAS  Google Scholar 

  97. Ruan, W. and Kleinberg, D. L. (1999). Insulin-like growth factor I is essential for terminal end bud formation and ductal morphogenesis during mammary development. Endocrinology 140(11): 5075–81.

    Article  PubMed  CAS  Google Scholar 

  98. Sachdev, D., Hartell, J. S., et al. (2004). A dominant negative type I insulin-like growth factor receptor inhibits metastasis of human cancer cells. J Biol Chem 279(6): 5017–24. Epub 2003 Nov 13.

    Article  PubMed  CAS  Google Scholar 

  99. Sachdev, D. and Yee, D. (2001). The IGF system and breast cancer. Endocr Relat Cancer 8(3): 197–209.

    Article  PubMed  CAS  Google Scholar 

  100. Salcedo, R., Wasserman, K., et al. (1999). Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha. Am J Pathol 154(4): 1125–35.

    Article  PubMed  CAS  Google Scholar 

  101. Schadendorf, D., Moller, A., et al. (1993). IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J Immunol 151(5): 2667–75.

    PubMed  CAS  Google Scholar 

  102. Schmid, B. C., Rudas, M., et al. (2004). CXCR4 is expressed in ductal carcinoma in situ of the breast and in atypical ductal hyperplasia. Breast Cancer Res Treat 84(3): 247–50.

    Article  PubMed  CAS  Google Scholar 

  103. Schneider, M. R., Hoeflich, A., et al. (2000). Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells. Cancer Lett 151(1): 31–8.

    Article  PubMed  CAS  Google Scholar 

  104. Scotton, C. J., Wilson, J. L., et al. (2002). Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Res 62(20): 5930–8.

    PubMed  CAS  Google Scholar 

  105. Simons, K. and Toomre, D. (2000). Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1(1): 31–9.

    Article  PubMed  CAS  Google Scholar 

  106. Singer, C. F., Kubista, E., et al. (2000). Local feedback mechanisms in human breast cancer. Breast Cancer Res Treat 63(2): 95–104.

    Article  PubMed  CAS  Google Scholar 

  107. Singh, R. K., Gutman, M., et al. (1994). Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res 54(12): 3242–7.

    PubMed  CAS  Google Scholar 

  108. Slamon, D. J., Clark, G. M., et al. (1987). Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235(4785): 177–82.

    Article  PubMed  CAS  Google Scholar 

  109. Slamon, D. J., Godolphin, W., et al. (1989). Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244(4905): 707–12.

    Article  PubMed  CAS  Google Scholar 

  110. Smith, M. C., Luker, K. E., et al. (2004). CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res 64(23): 8604–12.

    Article  PubMed  CAS  Google Scholar 

  111. Soriano, S. F., Hernanz-Falcon, P., et al. (2002). Functional inactivation of CXC chemokine receptor 4-mediated responses through SOCS3 up-regulation. J Exp Med 196(3): 311–21.

    Article  PubMed  CAS  Google Scholar 

  112. Speirs, V. and Kerin, M. J. (2000). Prognostic significance of oestrogen receptor beta in breast cancer. Br J Surg 87(4): 405–9.

    Article  PubMed  CAS  Google Scholar 

  113. Speirs, V., Parkes, A. T., et al. (1999). Coexpression of estrogen receptor alpha and beta: poor prognostic factors in human breast cancer? Cancer Res 59(3): 525–8.

    PubMed  CAS  Google Scholar 

  114. Spiegel, A. M. and Weinstein, L. S. (2004). Inherited diseases involving g proteins and g protein-coupled receptors. Annu Rev Med 55: 27–39.

    Article  PubMed  CAS  Google Scholar 

  115. Sporn, M. B. (1996). The war on cancer. Lancet 347(9012): 1377–81.

    Article  PubMed  CAS  Google Scholar 

  116. Strieter, R. M., Polverini, P. J., et al. (1995). The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 270(45): 27348–57.

    Article  PubMed  CAS  Google Scholar 

  117. Surmacz, E. (2000). Function of the IGF-I receptor in breast cancer. J Mammary Gland Biol Neoplasia 5(1): 95–105.

    Article  PubMed  CAS  Google Scholar 

  118. Surmacz, E., Guvakova, M. A., et al. (1998). Type I insulin-like growth factor receptor function in breast cancer. Breast Cancer Res Treat 47(3): 255–67.

    Article  PubMed  CAS  Google Scholar 

  119. Tachibana, K., Hirota, S., et al. (1998). The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 393(6685): 591–4.

    Article  PubMed  CAS  Google Scholar 

  120. Takanami, I. (2003). Overexpression of CCR7 mRNA in nonsmall cell lung cancer: correlation with lymph node metastasis. Int J Cancer 105(2): 186–9.

    Article  PubMed  CAS  Google Scholar 

  121. Tanaka, T., Z. Bai, et al. (2005). “Chemokines in tumor progression and metastasis.” Cancer Sci 96(6): 317–22.

    Google Scholar 

  122. Tanimoto, T., Lungu, A. O., et al. (2004). Sphingosine 1-phosphate transactivates the platelet-derived growth factor beta receptor and epidermal growth factor receptor in vascular smooth muscle cells. Circ Res 94(8): 1050–8. Epub 2004 Mar 25.

    Article  PubMed  CAS  Google Scholar 

  123. Thelen, M. (2001). Dancing to the tune of chemokines. Nat Immunol 2(2): 129–34.

    Article  PubMed  CAS  Google Scholar 

  124. Trentin, L., Cabrelle, A., et al. (2004). Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas. Blood 104(2): 502–8. Epub 2004 Mar 4.

    Article  PubMed  CAS  Google Scholar 

  125. van Golen, K. L. (2003). Inflammatory breast cancer: relationship between growth factor signaling and motility in aggressive cancers. Breast Cancer Res 5(3): 174–9. Epub 2003 Apr 4.

    Article  PubMed  Google Scholar 

  126. Varney, M. L., Li, A., et al. (2003). Expression of CXCR1 and CXCR2 receptors in malignant melanoma with different metastatic potential and their role in interleukin-8 (CXCL-8)-mediated modulation of metastatic phenotype. Clin Exp Metastasis 20(8): 723–31.

    Article  PubMed  CAS  Google Scholar 

  127. Veltri, R. W., Miller, M. C., et al. (1999). Interleukin-8 serum levels in patients with benign prostatic hyperplasia and prostate cancer. Urology 53(1): 139–47.

    Article  PubMed  CAS  Google Scholar 

  128. Veronesi, U., Boyle, P., et al. (2005). Breast cancer. Lancet 365(9472): 1727–41.

    Article  PubMed  Google Scholar 

  129. Vicari, A. P. and Caux, C. (2002). "Chemokines in cancer. Cytokine Growth Factor Rev 13(2): 143–54.

    Article  PubMed  CAS  Google Scholar 

  130. Walden, P. D., Ruan, W., et al. (1998). Evidence that the mammary fat pad mediates the action of growth hormone in mammary gland development. Endocrinology 139(2): 659–62.

    Article  PubMed  CAS  Google Scholar 

  131. Waters, C., Pyne, S., et al. (2004). The role of G-protein coupled receptors and associated proteins in receptor tyrosine kinase signal transduction. Semin Cell Dev Biol 15(3): 309–23.

    Article  PubMed  CAS  Google Scholar 

  132. Weiss, L. (1996). Metastatic inefficiency: intravascular and intraperitoneal implantation of cancer cells. Cancer Treat Res 82: 1–11.

    Article  PubMed  CAS  Google Scholar 

  133. Wiley, H. E., Gonzalez, E. B., et al. (2001). Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. J Natl Cancer Inst 93(21): 1638–43.

    Article  PubMed  CAS  Google Scholar 

  134. Youngs, S. J., Ali, S. A., et al. (1997). Chemokines induce migrational responses in human breast carcinoma cell lines. Int J Cancer 71(2): 257–66.

    Article  PubMed  CAS  Google Scholar 

  135. Yu, D. and Hung, M. C. (2000). Overexpression of ErbB2 in cancer and ErbB2-targeting strategies. Oncogene 19(53): 6115–21.

    Article  PubMed  CAS  Google Scholar 

  136. Zhou, Y., Larsen, P. H., et al. (2002). CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J Biol Chem 277(51): 49481–7.

    Article  PubMed  CAS  Google Scholar 

  137. Zlotnik, A. and Yoshie, O., (2000). Chemokines: a new classification system and their role in immunity. Immunity 12(2): 121–7.

    Article  PubMed  CAS  Google Scholar 

  138. Zou, Y. R., Kottmann, A. H., et al. (1998). Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393(6685): 595–9.

    Article  PubMed  CAS  Google Scholar 

  139. Zwick, E., Bange, J., et al. (2001). Receptor tyrosine kinase signalling as a target for cancer intervention strategies. Endocr Relat Cancer 8(3): 161–73.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Chemokine Biology Laboratory, The School of Molecular and Biomedical Science, The University of Adelaide, Adelaide, SA 5005, Australia

    Chareeporn Akekawatchai, Marina Kochetkova, Jane Holland & Shaun R McColl

Authors
  1. Chareeporn Akekawatchai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marina Kochetkova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jane Holland
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shaun R McColl
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

    Rights and permissions

    Reprints and permissions

    Copyright information

    © 2009 Humana Press, a part of Springer Science+Business Media, LLC

    About this chapter

    Cite this chapter

    Akekawatchai, C., Kochetkova, M., Holland, J., McColl, S.R. (2009). Chemokines and Chemokine Receptors in Cancer Progression. In: Fulton, A. (eds) Chemokine Receptors in Cancer. Cancer Drug Discovery and Development. Humana Press. https://doi.org/10.1007/978-1-60327-267-4_1

    Download citation

    • DOI: https://doi.org/10.1007/978-1-60327-267-4_1

    • Published:

    • Publisher Name: Humana Press

    • Print ISBN: 978-1-60327-266-7

    • Online ISBN: 978-1-60327-267-4

    • eBook Packages: MedicineMedicine (R0)

    Publish with us

    Policies and ethics

    Search

    Navigation